Masimo (NASDAQ:MASI) EVP Yongsam Lee sold 4,100 shares of the stock in a transaction dated Tuesday, April 24th. The stock was sold at an average price of $90.13, for a total transaction of $369,533.00. Following the transaction, the executive vice president now directly owns 72,200 shares in the company, valued at approximately $6,507,386. The transaction was disclosed in a filing with the SEC, which is available through this link.

Yongsam Lee also recently made the following trade(s):

  • On Tuesday, March 13th, Yongsam Lee sold 100 shares of Masimo stock. The stock was sold at an average price of $90.00, for a total transaction of $9,000.00.
  • On Thursday, February 1st, Yongsam Lee sold 10,000 shares of Masimo stock. The stock was sold at an average price of $92.95, for a total transaction of $929,500.00.

MASI stock opened at $91.13 on Friday. Masimo has a 1 year low of $80.69 and a 1 year high of $104.71. The stock has a market cap of $4,600.59, a PE ratio of 37.20, a P/E/G ratio of 2.33 and a beta of 0.94.

Masimo (NASDAQ:MASI) last posted its earnings results on Tuesday, February 27th. The medical equipment provider reported $0.72 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.61 by $0.11. Masimo had a net margin of 16.49% and a return on equity of 22.75%. The company had revenue of $225.20 million for the quarter, compared to analyst estimates of $201.54 million. During the same quarter in the prior year, the business posted $0.46 EPS. The firm’s revenue was up 22.9% compared to the same quarter last year. research analysts forecast that Masimo will post 2.81 earnings per share for the current fiscal year.

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Old Mutual Global Investors UK Ltd. raised its holdings in shares of Masimo by 9.0% in the 4th quarter. Old Mutual Global Investors UK Ltd. now owns 881,000 shares of the medical equipment provider’s stock worth $74,708,000 after acquiring an additional 72,512 shares during the last quarter. Prudential Financial Inc. raised its holdings in shares of Masimo by 23.9% in the 3rd quarter. Prudential Financial Inc. now owns 685,268 shares of the medical equipment provider’s stock worth $59,317,000 after acquiring an additional 132,053 shares during the last quarter. American Century Companies Inc. raised its holdings in shares of Masimo by 23.1% in the 4th quarter. American Century Companies Inc. now owns 587,070 shares of the medical equipment provider’s stock worth $49,784,000 after acquiring an additional 110,107 shares during the last quarter. Schroder Investment Management Group raised its holdings in shares of Masimo by 38.4% in the 4th quarter. Schroder Investment Management Group now owns 468,020 shares of the medical equipment provider’s stock worth $39,687,000 after acquiring an additional 129,905 shares during the last quarter. Finally, Victory Capital Management Inc. raised its holdings in shares of Masimo by 36.4% in the 4th quarter. Victory Capital Management Inc. now owns 410,400 shares of the medical equipment provider’s stock worth $34,802,000 after acquiring an additional 109,470 shares during the last quarter. Institutional investors own 81.32% of the company’s stock.

MASI has been the topic of a number of research analyst reports. Zacks Investment Research cut shares of Masimo from a “buy” rating to a “hold” rating in a research report on Wednesday, February 7th. Barclays initiated coverage on shares of Masimo in a research report on Friday, March 9th. They set an “overweight” rating and a $97.00 price objective on the stock. BidaskClub raised shares of Masimo from a “hold” rating to a “buy” rating in a research report on Tuesday. Finally, Piper Jaffray reissued a “hold” rating and set a $91.00 price objective on shares of Masimo in a research report on Thursday, March 1st. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $101.00.

About Masimo

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Insider Buying and Selling by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.